These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25027226)

  • 41. An evaluation of the use of a negative interferon-γ release assay for tuberculosis screening before TNF antagonist therapy.
    Woodfield G; Passey-Heaton B; Chakrabarti A; Pozniak A; Loebinger MR
    Eur Respir J; 2014 Nov; 44(5):1369-72. PubMed ID: 25186258
    [No Abstract]   [Full Text] [Related]  

  • 42. [Tuberculosis screening in school health services in Geneva, Switzerland].
    Meynard A; Pfarrwaller E; Lazarevic CA
    Rev Med Suisse; 2016 Jun; 12(522):1125-8. PubMed ID: 27451510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the use of the interferon-γ response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-α therapy: a prospective head-to-head cross-sectional study.
    Martyn-Simmons CL; Mee JB; Kirkham BW; Groves RW; Milburn HJ
    Br J Dermatol; 2013 May; 168(5):1012-8. PubMed ID: 23278714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Latent tuberculosis infection is prevalent among socially marginalised citizens in Aarhus, Denmark.
    Stærke NB; Hilberg O; Wejse C; Hoffmann HJ; Fløe A
    Dan Med J; 2016 Jul; 63(7):. PubMed ID: 27399979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tuberculosis among patients in Israel with anti-TNF].
    Ahmed A; Guber A; Shitrit D
    Harefuah; 2015 Jul; 154(7):419-22, 470. PubMed ID: 26380458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 47. The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry.
    Tomsic M; Rotar Z
    Ann Rheum Dis; 2012 Nov; 71(11):1909-11. PubMed ID: 22805974
    [No Abstract]   [Full Text] [Related]  

  • 48. The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
    Jung YJ; Lee JY; Jo KW; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):428-34. PubMed ID: 24670697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An interferon-gamma release assay test performs well in routine screening for tuberculosis.
    Danielsen AV; Fløe A; Lillebaek T; Hoffmann HJ; Hilberg O
    Dan Med J; 2014 Jun; 61(6):A4856. PubMed ID: 24947627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon-gamma release assays and the diagnosis of tuberculosis: have they found their place?
    Darby J; Black J; Buising K
    Intern Med J; 2014 Jul; 44(7):624-32. PubMed ID: 25041769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris RJ; Collin SM; Muzyamba MC; Conroy OD; Mirza A; O'Connell AM; Altass L; Anderson SR; Thomas HL; Campbell C; Zenner D; Phin N; Kon OM; Smith EG; Lalvani A
    Lancet Public Health; 2022 Apr; 7(4):e305-e315. PubMed ID: 35338849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Towards better management of latent tuberculosis infection in children and young adults in the Maghreb. Conclusions of an expert meeting, Paris, 16 March 2018.
    Delacourt C; Zellweger JP;
    Arch Pediatr; 2019 Feb; 26(2):126-129. PubMed ID: 30642745
    [No Abstract]   [Full Text] [Related]  

  • 55. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH; Yim JJ; Kim HJ; Shim TS; Seo HS; Cho YS; Lee HK; Lee YM; Lee EJ; Lew WJ
    Epidemiol Infect; 2012 Jun; 140(6):1028-35. PubMed ID: 21835069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk for latent and active tuberculosis in Germany.
    Herzmann C; Sotgiu G; Bellinger O; Diel R; Gerdes S; Goetsch U; Heykes-Uden H; Schaberg T; Lange C;
    Infection; 2017 Jun; 45(3):283-290. PubMed ID: 27866367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
    Davidow AL
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.
    Theodoropoulos N; Lanternier F; Rassiwala J; McNatt G; Preczewski L; DeMayo E; Stosor V; Ison MG
    Transpl Infect Dis; 2012 Feb; 14(1):1-8. PubMed ID: 21883759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug therapy for children with tuberculosis.
    Ormerod LP
    Arch Dis Child; 2012 Dec; 97(12):1097-101. PubMed ID: 23104773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.